{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:48:31Z","timestamp":1794541711655,"version":"4.9.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12889-018-6183-1","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T11:26:23Z","timestamp":1543922783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Distribution pattern of poliovirus potentially infectious materials in the phase 1b medical laboratories containment in conformity with the global action plan III"],"prefix":"10.1186","volume":"18","author":[{"given":"Bassey Enya","family":"Bassey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Braka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Shuaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Banda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisay Gashu","family":"Tegegne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnson Muluh","family":"Ticha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walla Hamisu","family":"Abdullalhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olatunji Mathew","family":"Kolawole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,13]]},"reference":[{"key":"6183_CR1","unstructured":"World Health Organization. WHO EMRO | Laboratory containment of wild polio virus and potential infectious material | Certification-containment | Polio eradication initiative. \n                    http:\/\/www.emro.who.int\/polio\/certification-containment\/laboratory-containment-of-wild-polio-virus-and-potential-infectious-material.html\n                    \n                  . Accessed 20 Dec 2016."},{"key":"6183_CR2","volume-title":"SEARO","author":"World Health Organization, Polio-free certification: WHO south-East Asia","year":"2016","unstructured":"World Health Organization, Polio-free certification: WHO south-East Asia. SEARO. 2016."},{"key":"6183_CR3","unstructured":"Renne EP. Polio in Nigeria."},{"key":"6183_CR4","unstructured":"Progress Toward Interruption of Wild Poliovirus Transmission. Morb Mortal Wkly Rep. 2007:682\u20135. \n                    https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17625496\n                    \n                  ."},{"key":"6183_CR5","volume-title":"WHO","year":"2016","unstructured":"WHO | Wild polio and vaccine derived polio in Nigeria. WHO. 2016."},{"key":"6183_CR6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.15585\/mmwr.mm6530a4","volume":"65","author":"A Etsano","year":"2016","unstructured":"Etsano A, Damisa E, Shuaib F, wa NG, Enemaku O, Usman S, et al. Environmental isolation of circulating vaccine-derived poliovirus after interruption of wild poliovirus transmission \u2014 Nigeria, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:770\u20133. \n                    https:\/\/doi.org\/10.15585\/mmwr.mm6530a4\n                    \n                  .","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6183_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.11648\/j.sjph.20160404.19","volume":"4","author":"J-E Abubakar Saleh","year":"2016","unstructured":"Abubakar Saleh J-E, Vaz RG, Braka F, Abdelrahim K, Ningi AI. A critical look at 2015 acute flaccid paralysis (AFP) surveillance Core indicators of Bauchi state, Nigeria. Sci J Public Heal. 2016;4:326. \n                    https:\/\/doi.org\/10.11648\/j.sjph.20160404.19\n                    \n                  .","journal-title":"Sci J Public Heal"},{"key":"6183_CR8","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1001\/jama.2016.6686","volume":"315","author":"MJ Friedrich","year":"2016","unstructured":"Friedrich MJ. Switch from trivalent to bivalent Oral polio vaccine. JAMA. 2016;315:2513. \n                    https:\/\/doi.org\/10.1001\/jama.2016.6686\n                    \n                  .","journal-title":"JAMA"},{"key":"6183_CR9","unstructured":"World Health Organisation. Unprecedented support pervades as Nigeria officially \u201cswitch\u201d to bivalent Oral Polio Vaccine - WHO | Regional Office for Africa \n                    http:\/\/www.afro.who.int\/en\/nigeria\/press-materials\/item\/8544-unprecedented-support-pervades-as-nigeria-officially-switch-to-bivalent-oral-polio-vaccine.html\n                    \n                  . Accessed 19 Dec 2016."},{"issue":"Suppl 1","key":"6183_CR10","first-page":"S65","volume":"53","author":"VM Vashishtha","year":"2016","unstructured":"Indian Academy of Pediatrics (IAP) advisory committee on vaccines and immunization practices (ACVIP), Vashishtha VM, Choudhary J, Yadav S, Unni JC, Jog P, et al. Introduction of Inactivated Poliovirus Vaccine in National Immunization Program and Polio Endgame Strategy. Indian Pediatr. 2016;53(Suppl 1):S65\u20139 \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27133231\n                    \n                  . Accessed 19 Dec 2016.","journal-title":"Indian Pediatr"},{"key":"6183_CR11","volume-title":"Laboratory containment of poliovirus in the United States phase II (poliovirus type 2)","author":"O Kew","year":"2016","unstructured":"Kew O. Laboratory containment of poliovirus in the United States phase II (poliovirus type 2); 2016."},{"issue":"suppl_1","key":"6183_CR12","doi-asserted-by":"publisher","first-page":"S454","DOI":"10.1093\/infdis\/jit821","volume":"210","author":"Christopher Wolff","year":"2014","unstructured":"Wolff C, Roesel S, Lipskaya G, Landaverde M, Humayun A, Withana N, et al. Progress toward laboratory containment of poliovirus after polio eradication. J Infect Dis. 2014;(suppl 1):S454\u20138. \n                    https:\/\/doi.org\/10.1093\/infdis\/jit821\n                    \n                  .","journal-title":"The Journal of Infectious Diseases"},{"key":"6183_CR13","volume-title":"World Health Organization guidelines for containment of poliovirus following type-specific polio eradication \u2014 worldwide","author":"N Previsani","year":"2015","unstructured":"Nicoletta Previsani, Rudolph H. Tangermann, Graham Tallis, Hamid S. Jafari M. World Health Organization guidelines for containment of poliovirus following type-specific polio eradication \u2014 worldwide, 2015. \n                    https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6433a5.htm\n                    \n                  . Accessed 19 Dec 2016."},{"key":"6183_CR14","first-page":"384","volume":"7","author":"A Aplogan","year":"1997","unstructured":"Aplogan A, Batchassi E, Yakoua Y, Croisier A, Aleki A, Schlumberger M, et al. An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies. Sante. 1997;7:384\u201390 \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9503496\n                    \n                  . Accessed 26 Aug 2015.","journal-title":"Sante"},{"key":"6183_CR15","unstructured":"Guidelines for Implementation of Laboratory Containment of Wild Poliovirus. 2000."},{"key":"6183_CR16","volume-title":"Safe Disposal of Infectious Laboratory Waste","author":"Laboratory NRC (US) C on HBS in the","year":"1989","unstructured":"Laboratory NRC (US) C on HBS in the. Safe Disposal of Infectious Laboratory Waste. 1989."},{"key":"6183_CR17","unstructured":"Mondiale La Sante O DE. WOR LD H EA LTH OR GA NIZA TION Key Points: Containment of Poliovirus Type 2 Materials. \n                    www.who.int\n                    \n                  . Accessed 20 Dec 2016."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-6183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-018-6183-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-6183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:05:07Z","timestamp":1576195507000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-018-6183-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":17,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["6183"],"URL":"https:\/\/doi.org\/10.1186\/s12889-018-6183-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"13 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of the Cross River State Ministry of Health approved this study. Reference: (CRS\/MH\/CGSE-H\/018\/Vol\/126). Verbally informed consents were obtained from all the participants in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1319"}}